ThinkCyte
PrivateLast Round
Grant
Aug 4, 2025
Total Funding Raised
$105.9M
Company Overview
ThinkCyte is a biotechnology company that develops an image-based cell sorting technology designed to advance single-cell analysis for research, diagnostics, and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Medical AI, Biotechnology, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThinkCyte Comps
Public and private peers based on sector, stage, and business model.
ThinkCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 4, 2025 | ||||
| Debt | Aug 29, 2024 | ||||
| Series C Extension | Aug 29, 2024 | ||||
| Grant | Nov 28, 2023 | ||||
| Series C | Nov 28, 2023 | ||||
Series B | May 19, 2021 |
Key People
Founding team and executive leadership
ThinkCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIRIN-GB Fund I L.P. | Series C Extension |
| Sumitomo Mitsui Trust Bank | Series C |
| 株式会社日本政策金融公庫 | Debt |
| SMBC Venture Capital No. 7 Investment Limited Partnership | Series C Extension |
| JAPAN GREEN INVESTMENT CORP. FOR CARBON NEUTRALITY (JICN) | Series C Extension |
| Tokyo Century | Series C |
| ITOCHU Technology Ventures | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2025
Added Almog Diagnostic & Medical Equipment Ltd. as a customer.
- Jun 3, 2025
Launched MorphoScan Cloud, a cloud-based platform for AI-driven cell morphology analysis.
ThinkCyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ThinkCyte's valuation, stock price, and market status.
